These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38518226)

  • 1. Evaluation of potential prevalence of onconeural antibodies in women with breast cancer.
    Krolewska-Daszczynska P; Smycz-Kubanska M; Kruszniewska-Rajs C; Kabut J; Olczyk P; Gola J; Mielczarek-Palacz A
    Pol Merkur Lekarski; 2024; 52(1):5-9. PubMed ID: 38518226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
    Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
    J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onconeural Antibodies in Acute Psychiatric Inpatient Care.
    Sæther SG; Schou M; Stoecker W; Teegen B; Borowski K; Vaaler A; Kondziella D; Reitan SK
    J Neuropsychiatry Clin Neurosci; 2017; 29(1):74-76. PubMed ID: 27578448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex serology of paraneoplastic antineuronal antibodies.
    Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
    J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.
    Berger B; Hottenrott T; Rauer S; Stich O
    BMC Neurol; 2017 Jan; 17(1):5. PubMed ID: 28068933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
    Raspotnig M; Vedeler CA; Storstein A
    Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic neurologic syndromes: laboratory diagnostics and immunological aspects].
    Hayden Z; Böröcz K; Csizmadia Z; Kellermayer Z; Balogh P; Berki T
    Magy Onkol; 2019 Sep; 63(3):261-267. PubMed ID: 31533147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.
    Déchelotte B; Muñiz-Castrillo S; Joubert B; Vogrig A; Picard G; Rogemond V; Pinto AL; Lombard C; Desestret V; Fabien N; Honnorat J
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32170044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes.
    Berger B; Stich O; Labeit S; Rauer S
    J Neuroimmunol; 2016 Jun; 295-296():18-20. PubMed ID: 27235344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
    Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
    BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant SOX-1 antibodies results in paraneoplastic Lambert-Eaton syndrome diagnosis by the clinical laboratory.
    Pozo-Giraldez A; Rodríguez-Borja E; Diaz-Gimenez M; Carratala-Calvo A; Magro-Pose P; Perez-Griera J
    Clin Biochem; 2021 Nov; 97():82-84. PubMed ID: 34450126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
    Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
    Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond paraneoplastic neurological syndromes: Anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosus.
    Manikuppam P; Prakash JAJ; Yadav B; Mathew J
    Lupus; 2024 Oct; 33(11):1227-1234. PubMed ID: 39167163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested.
    Ruiz-García R; Martínez-Hernández E; Saiz A; Dalmau J; Graus F
    Front Immunol; 2020; 11():1482. PubMed ID: 32760403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.
    Shah S; Vazquez Do Campo R; Kumar N; McKeon A; Flanagan EP; Klein C; Pittock SJ; Dubey D
    Neurology; 2021 Jan; 96(4):e632-e639. PubMed ID: 33208548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
    Fu P; He L; Tang N; Nie Q; Li Z
    J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature.
    Sena G; Gallo G; Vescio G; Gambardella D; de Franciscis S; Renne M
    J Med Case Rep; 2020 Jun; 14(1):67. PubMed ID: 32527295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.